Pancragen 20 mg

Pancragen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a tetrapeptide oligopeptide directed at pancreatic tissue, Pancragen was developed to investigate how minimal peptide sequences interact with pancreatic cell models and glucose-regulation research systems. Its compact structure positions Pancragen as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Pancragen is studied for its proposed ability to engage with chromatin and modulate transcriptional activity within pancreatic cell models, including acinar and islet cell research systems. Research observations within the Khavinson framework suggest that short bioregulator peptides may interact with specific DNA regions to influence the expression of genes associated with pancreatic enzyme synthesis, beta-cell signaling, and tissue homeostasis. These interactions are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Pancragen centers on pancreatic gene expression studies, beta-cell-related research, and investigations of glucose-regulation research models. Comparative work on tissue-specific bioregulators positions Pancragen alongside other pancreas-targeted oligopeptides used to explore peptidergic regulation of pancreatic biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how short peptides modulate proliferation, differentiation, and apoptosis within target tissues, supporting continued laboratory investigation of Pancragen in pancreatic-biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Cardiogen 20 mg, Ovagen 20 mg, and Livagen 20 mg.

Specifications

• Purity: 99%
• Quantity: 20 mg
• Molecular Formula: C₂₆H₃₆N₆O₉
• Molecular Weight: 576.65 g/mol